Riociguat for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH): Responder Analysis of Who Functional Class III Patients from the Patent-1 Study
2013
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI